Summary
The effect of i.m. administration of 75 mg of desipramine on growth hormone (GH) secretion was investigated in a sample of 87 patients with major depressive disorders and in 31 normal controls. The GH response was lower in depressed females compared to depressed males, but no such difference was present in controls. In the premenopausal female group, GH response was significantly lower in depressed patients than in controls. No significant difference was found between normal males and male depressed patients. In the premenopausal group, no difference emerged between endogenous and nonendogenous depressed women.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ceska M, Lundkvist U (1972) A new and simple radioimmunoassay method for determination of IgE. Immunochemistry 9:1021–1030
Checkley SA, Slade AP, Shur E (1981) Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 138:51–55
Gruen PH, Sachar EJ, Altman N, Sassin J (1975) Growth hormone responses to hypoglycemia in postmenopausal depressed women. Arch Gen Psychiatry 32:31–33
Halbreich U, Sachar EJ, Asnis GM, Quitkin F, Nathan RS, Halpern FS, Klein DF (1982) Growth hormone response to dextroamphetamine in depressed patients and normal subjects. Arch Gen Psychiatry 39:189–192
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr 23:56–62
Laakman G (1980) Neuroendocrinological findings in affective disorders after administration of antidepressants. Psychoneuroendocrinology and abnormal behavior. Adv Biol Psychiat 5:67–84
Laakman G, Schumacher G, Benkert O (1977) Stimulation of growth hormone secretion by desimipramine and chlorimipramine in man. J Clin Endrocrinol Metab 44:1010–1013
Langer G, Heinze G, Reim B, Matussek N (1976) Reduced growth hormone response to amphetamine in “endogenous” depressive patients. Arch Gen Psychiatry 33:1471–1476
Mattusek N, Ackenheil M, Hippius H, Muller F, Schröder HT, Schultes H, Wasilewski B (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res 2:25–36
Matussek N, Laakman G (1981) Growth hormone response in patients with depression. Acta Psychiatr Scand [Suppl 2901 vol 63
Mendlewicz J, Linkowski P (1977) Growth hormone response to levodopa in affective illness. Lancet I:652–653
Sachar EJ, Finkelstein J, Hellman L (1971) Growth hormone response in depressive illness. Response to insulin tolerance test. Arch Gen Psychiatry 25:263–270
Sachar EJ, Mushrush G, Perlow M, Weitzman ED, Sassin J (1972) Growth hormone response to L-dopa in depressed patients. Science 178:1304–1305
Sachar EJ, Altman N, Gruen PH, Glassman A, Halpern FS, Sassin J (1975) Human growth hormone response to levodopa. Arch Gen Psychiatry 32:502–503
Snedecor GW, Cochran WG (1967) Statistical methods, 6th end. The Iowa State University Press, Ames, Iowa, USA
Spitzer RL, Endicott J, Robbins E (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35:773–782
Wide L (1971) Radioimmunoassay methods. Kirham VE, Hunter WM (eds) Churchill Livingstone, Edinburgh, 405
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meesters, P., Kerkhofs, M., Charles, G. et al. Growth hormone release after desipramine in depressive illness. Eur Arch Psychiatr Neurol Sci 235, 140–142 (1985). https://doi.org/10.1007/BF00380983
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00380983